EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

HEV in Blood Donors in Switzerland: The Route to Safe Blood Products

Mauro Serricchio iD, Peter Gowland, Nadja Widmer, Martin Stolz, Christoph Niederhauser iD

Pathogens · 18.10.2024 · 13 (10) · 911

DOI: 10.3390/pathogens13100911 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathogens, online erschienen am 18.10.2024. Verfasst von Mauro Serricchio und 4 weiteren Autor:innen. Beteiligte Einrichtung: Interregional Blood Transfusion SRC, 3008 Bern, Switzerland. Hauptthemen laut MEDLINE: Blood Donors, Hepatitis E, Hepatitis E virus. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Humanitarian Foundation of the Swiss Red Cross.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The hepatitis E virus (HEV) is an emerging infectious disease with zoonotic potential, causing acute hepatitis in humans. Infections in healthy individuals are often acute, self-limiting and asymptomatic, thus leading to the underdiagnosis of HEV infections. Asymptomatic HEV infections pose a problem for blood transfusion safety by increasing the risk for transfusion-transmitted HEV infections. Here, we describe the journey from determining the HEV seroprevalence among blood donors to the implementation of routine HEV RNA testing of all blood products in Switzerland in 2018 and summarise the HEV cases detected since. In total, 290 HEV-positive blood donations were detected by mini-pool nucleic acid testing (NAT) in Switzerland in the period of October 2018–December 2023, equal to an incidence of 20.7 per 100,000 donations. Thanks to the implemented scheme, no transfusion-transmitted infections occurred in this period. Furthermore, blood donation monitoring has proven to be an effective means of detecting HEV outbreaks in the general population. HEV cases in Swiss blood donors are caused by two major genotypes, the Swiss-endemic subtypes 3h3 and 3c. Interestingly, 11 HEV cases (5%) were of genotype 3ra, a variant found in wild and farmed rabbits. Our results indicate that mini-pool NAT is an efficient method to reduce the risk of transfusion-transmitted HEV infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood DonorsHepatitis EHepatitis E virusHumansSwitzerlandMaleAdultFemaleMiddle AgedSeroepidemiologic StudiesAnimalsGenotypeYoung AdultBlood SafetyAdolescentAgedRNA, Viral

Stichwörter der Autor:innen

HEVSwitzerlandblood donorsepidemiologygenotypehepatitis E virusinfectious diseaseseroprevalencesurveillancetransfusion safety

Substanzen

RNA, Viral

Autor:innen und Institutionen

  • Interregional Blood Transfusion SRC, 3008 Bern, Switzerland.
  • Institute for Infectious Diseases, University of Bern, 3012 Bern, Switzerland.

ORCID-Profile: Mauro Serricchio, Christoph Niederhauser

Förderung

  • Humanitarian Foundation of the Swiss Red Cross

Zitieren

APA

Serricchio, M., Gowland, P., Widmer, N., Stolz, M., & Niederhauser, C. (2024). HEV in Blood Donors in Switzerland: The Route to Safe Blood Products. Pathogens, 13(10), 911. https://doi.org/10.3390/pathogens13100911

Vancouver

Serricchio M, Gowland P, Widmer N, Stolz M, Niederhauser C. HEV in Blood Donors in Switzerland: The Route to Safe Blood Products. Pathogens. 2024;13(10):911. doi:10.3390/pathogens13100911

BibTeX
@article{Serricchio2024,
  author = {Serricchio, Mauro and Gowland, Peter and Widmer, Nadja and Stolz, Martin and Niederhauser, Christoph},
  title = {HEV in Blood Donors in Switzerland: The Route to Safe Blood Products},
  journal = {Pathogens},
  year = {2024},
  volume = {13},
  number = {10},
  pages = {911},
  doi = {10.3390/pathogens13100911}
}
Kostenlos starten →